Thomas Kurian, CEO of Google Cloud, speaks at a cloud computing conference held by the company in 2019.
Michael Short | Bloomberg | Getty Images
Google Cloud on Monday announced new artificial intelligence-powered search capabilities that it said will help health-care workers quickly pull accurate clinical information from different types of medical records.
The health-care industry is home to troves of valuable information and data, but it can be challenging for clinicians to find since it’s often stored across multiple systems and formats. Google Cloud’s new search tool will allow doctors to pull information from clinical notes, scanned documents and electronic health records so it can be accessed in one place.
The company said the new capabilities will ultimately save health-care workers a significant amount of time and energy.
“While it should save time to be able to do that search, it should also prevent frustration on behalf of clinicians and [make] sure that they get to an answer easier,” Lisa O’Malley, senior director of product management for Cloud AI at Google Cloud told CNBC in an interview.
For instance, if doctors want to know about a patient’s history, they no longer need to read through their notes, faxes and electronic health records separately. Instead, they can search questions such as “What medications has this patient taken in the last 12 months?” and see the relevant information in one place.
Google’s new search capabilities can also be used for other crucial applications such as applying the correct billing codes and determining whether patients meet the criteria to enroll in a clinical trial, O’Malley said.
She added that the technology can cite and link to the original source of the information, which will come directly from an organization’s own internal data. This should help alleviate clinicians’ concerns that the AI might be hallucinating, or generating inaccurate responses.
Google Cloud headquarters in Sunnyvale, California.
Google Cloud
The search features will be especially valuable to health-care workers who are already burdened with staffing shortages and daunting amounts of clerical paperwork.
A study funded by the American Medical Association in 2016 found that for every hour a physician spent with a patient, they spent an additional two hours on administrative work. The study said physicians also tend to spend an additional one to two hours doing clerical work outside of working hours, which many in the industry refer to as “pajama time.”
In 2022, 53% of physicians reported that they were feeling burned out, up from 42% in 2018, according to a January survey from Medscape.
Google hopes its new search offerings will reduce the amount of time clinicians need to spend digging through additional records and databases.
“Anything that Google can do by applying our search technologies, our health-care technologies and research capabilities to make the journey of the clinicians and health-care providers and payers more quick, more efficient, saving them cost, I think ultimately benefits us as patients,” O’Malley said.
The new features will be offered to health and life sciences organizations through Google’s Vertex AI Search platform, which companies in other industries can already use to conduct searches across public websites, documents and other databases. The specific offering for health care builds on Google’s existing Healthcare API and Healthcare Data Engine products.
Aashima Gupta, global director of health care strategy and solutions at Google Cloud, said the new Vertex AI Search capabilities can integrate directly into a clinician’s workflow, which is of high importance for customers in the field.
The health-care industry has historically been more hesitant to embrace new technology, and adoption can be even harder if health-care workers find new solutions distracting or hard to work with. It’s something Gupta said Google has been paying close attention to.
“These are the workflows that the physicians and nurses live by day in and day out. You can’t be adding friction to it,” Gupta told CNBC in an interview. “We are very cautious of that — that we are respecting the surface they use, that the workflow doesn’t change, but yet they get the power of this technology.”
Customers can sign up for early access to Vertex AI Search for health care and life sciences starting Monday, but Google Cloud has already been testing the capabilities with health organizations such as Mayo Clinic, Hackensack Meridian Health and Highmark Health.
Mayo Clinic is not using the new Vertex AI Search tools in clinical care yet, said Cris Ross, Mayo’s chief information officer; it is starting with administrative use cases.
“We are curious, we’re enthusiastic, we’re also careful,” he told CNBC in an interview. “And we’re not going to put anything into patient care until it’s really ready to be in patient care.”
Down the line, Ross said, Mayo Clinic is looking to explore how Vertex AI Search tools could be used to help nurses summarize long surgical notes, sort through patients’ complex medical histories, and easily answer questions such as “What is the smoking status of this patient?” But for now, the organization is starting slow and examining where AI solutions like Google’s will be the most useful.
Richard Clarke, chief analytics officer at Highmark Health, said the initial reaction to the search tools at the organization has been “tremendous” and the company already has a backlog of more than 200 use-case ideas. But similar to Mayo Clinic, he said the challenge will be prioritizing where the technology can be most useful, building employees’ trust in it and deploying it at scale.
“This is still very early days, deployed with small teams with lots of support, really thinking about this,” Clarke told CNBC in an interview. “We haven’t gone big and wide yet, but all early signs say that this is going to be tremendously useful, and frankly, in many cases, transformational for us.”
Google Cloud does not access customer data or use it to train models, and the company said the new service is compliant with the Health Insurance Portability and Accountability Act, or HIPAA.
Gupta said that as a patient, interacting with the health-care system can feel like a very fragmented and challenging experience, so she is excited to see how clinicians can ultimately leverage Google’s new tools to create a fuller picture.
“To me, connecting the dots from the patient perspective has long been health care’s journey, but it’s hard,” Gupta said. “Now, we are at a point where AI is being helpful in these very practical use cases.”
FILE PHOTO: Ariel Cohen during a panel at DLD Munich Conference 2020, Europe’s big innovation conference, Alte Kongresshalle, Munich.
Picture Alliance for DLD | Hubert Burda Media | AP
Navan, a developer of corporate travel and expense software, expects its market cap to be as high as $6.5 billion in its IPO, according to an updated regulatory filing on Friday.
The company said it anticipates selling shares at $24 to $26 each. Its valuation in that range would be about $3 billion less than where private investors valued Navan in 2022, when the company announced a $300 million funding round.
CoreWeave, Circle and Figma have led a resurgence in tech IPOs in 2025 after a drought that lasted about three years. Navan filed its original prospectus on Sept. 19, with plans to trade on the Nasdaq under the ticker symbol “NAVN.”
Last week, the U.S. government entered a shutdown that has substantially reduced operations inside of agencies including the SEC. In August, the agency said its electronic filing system, EDGAR, “is operated pursuant to a contract and thus will remain fully functional as long as funding for the contractor remains available through permitted means.”
Cerebras, which makes artificial intelligence chips, withdrew its registration for an IPO days after the shutdown began.
Navan CEO Ariel Cohen and technology chief Ilan Twig started the company under the name TripActions in 2015. It’s based in Palo Alto, California, and had around 3,400 employees at the end of July.
For the July quarter, Navan recorded a $38.6 million net loss on $172 million in revenue, which was up about 29% year over year. Competitors include Expensify, Oracle and SAP. Expensify stock closed at $1.64on Friday, down from its $27 IPO price in 2021.
Navan ranked 39th on CNBC’s 2025 Disruptor 50 list, after also appearing in 2024.
Jensen Huang, CEO of Nvidia, speaking with CNBC’s Jim Cramer during a CNBC Investing Club with Jim Cramer event at the New York Stock Exchange on Oct. 7th, 2025.
Kevin Stankiewicz | CNBC
Shares of Amazon, Nvidia and Tesla each dropped around 5% on Friday, as tech’s megacaps lost $770 billion in market cap, following President Donald Trump’s threats for increased tariffs on Chinese goods.
With tech’s trillion-dollar companies occupying an increasingly large slice of the U.S. market, their declines send the Nasdaq down 3.6% and the S&P 500 down 2.7%. For both indexes, it was the worst day since April, when Trump said he would slap “reciprocal” duties on U.S. trading partners.
After market close on Friday, Trump declared in a social media post that the U.S. would impose a 100% tariff on China and on Nov. 1 it would apply export controls “on any and all critical software.”
Amazon, Nvidia and Tesla all slipped about 2% in extended trading following the post.
The president’s latest threats are disrupting, at least briefly, what had been a sustained rally in tech, built on hundreds of billions of dollars in planned spending on artificial intelligence infrastructure.
Read more CNBC tech news
In late September, Nvidia, which makes graphics processing units for training AI models, became the first company to reach a market cap of $4.5 trillion. Nvidia alone saw its market capitalization decline by nearly $229 billion on Friday.
OpenAI counts on Nvidia’s GPUs from a series of cloud suppliers, including Microsoft. OpenAI is only seeing rising demand.
In September it introduced the Sora 2 video creation app, and this week the company said the ChatGPT assistant now boasts over 800 million weekly users. But Microsoft must buy infrastructure to operate its cloud data centers. Microsoft’s market cap dropped by $85 billion on Friday.
The sell-off wiped out Amazon’s gains for the year. That stock is now down 2% so far in 2025. It competes with Microsoft to rent out GPUs from its cloud data centers, but it doesn’t have major business with OpenAI. The online retailer is now worth $121 billion less than it was on Thursday.
“There continues to be a lot of noise about the impact that tariffs will have on retail prices and consumption,” Amazon CEO Andy Jassy told analysts in July. “Much of it thus far has been wrong and misreported. As we said before, it’s impossible to know what will happen.”
Tesla, which introduced lower-priced vehicles on Tuesday, saw its market capitalization sink by $71 billion.
The automaker reports third-quarter results on Oct. 22, with Microsoft earnings scheduled for the following week. Nvidia reports in November.
Google parent Alphabet and Facebook owner Meta fell 2% and almost 4%, respectively.
Govini, a defense tech software startup taking on the likes of Palantir, has blown past $100 million in annual recurring revenue, the company announced Friday.
“We’re growing faster than 100% in a three-year CAGR, and I expect that next year we’ll continue to do the same,” CEO Tara Murphy Dougherty told CNBC’s Morgan Brennan in an interview. With how “big this market is, we can keep growing for a long, long time, and that’s really exciting.”
CAGR stands for compound annual growth rate, a measurement of the rate of return.
The Arlington, Virginia-based company also announced a $150 million growth investment from Bain Capital. It plans to use the money to expand its team and product offering to satisfy growing security demands.
In recent years, venture capitalists have poured more money into defense tech startups like Govini to satisfy heightened national security concerns and modernize the military as global conflict ensues.
The group, which includes unicorns like Palmer Luckey’s Anduril, Shield AI and artificial intelligence beneficiary Palantir, is taking on legacy giants such as Boeing, Lockheed Martin and Northrop Grumman, that have long leaned on contracts from the Pentagon.
Read more CNBC tech news
Dougherty, who previously worked at Palantir, said she hopes the company can seize a “vertical slice” of the defense technology space.
The 14-year-old Govini has already secured a string of big wins in recent years, including an over $900-million U.S. government contract and deals with the Department of War.
Govini is known for its flagship AI software Ark, which it says can help modernize the military’s defense tech supply chain by better managing product lifecycles as military needs grow more sophisticated.
“If the United States can get this acquisition system right, it can actually be a decisive advantage for us,” Dougherty said.
Looking ahead, Dougherty told CNBC that she anticipates some setbacks from the government shutdown.
Navy customers could be particularly hard hit, and that could put the U.S. at a major disadvantage.
While the U.S. is maintaining its AI dominance, China is outpacing its shipbuilding capacity and that needs to be taken “very seriously,” she added.